01/10/2025
5:06 PM | NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
01/10/2025
6:03 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
6:00 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
3:12 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
12/09/2024
6:05 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/26/2024
3:08 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/22/2024
3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
7:10 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/13/2024
4:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/12/2024
3:52 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/08/2024
4:31 PM | Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
11/06/2024
3:46 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:15 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:19 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
10/16/2024
3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:19 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFM14A | |
09/25/2024
4:17 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form PREM14A | |
09/20/2024
7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
07/29/2024
3:25 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
6:18 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 424B4 | |
07/26/2024
4:19 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form POS EX | |
07/25/2024
11:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form EFFECT | |
07/24/2024
7:49 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/12/2024
5:21 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/11/2024
7:50 AM | NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/11/2024
7:45 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:05 PM | NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/10/2024
8:30 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
06/28/2024
3:21 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 424B3 | |
06/28/2024
2:19 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/27/2024
11:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form EFFECT | |
06/21/2024
4:26 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/20/2024
4:12 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/14/2024
7:47 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:30 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
3:50 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
3:43 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K/A | |
05/30/2024
8:24 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
WU MIJIA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:27 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Sit Swan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:29 PM | Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Please take this warning seriously... (Ad) I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days.
In fact, I believe it could begin as soon as January 29th…
Meaning you don’t have much time to prepare. Click here like your financial health depends on it. |
05/30/2024
8:31 PM | Garlikov Julie (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:17 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yongxiang (Reporting)
Zheng Yongxiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:22 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yenyou (Reporting)
Zheng Yenyou (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:27 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:04 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
4:21 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
8:15 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form ARS | |
04/18/2024
8:00 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024
8:06 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
04/08/2024
3:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024
11:27 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/29/2024
10:00 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 10-K/A | |
03/26/2024
3:14 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:30 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
6:30 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
7:30 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:52 PM | ARMISTICE CAPITAL, LLC (Filed by)
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
10:52 AM | Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
